Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

NCT04054362 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Paclitaxel protein bound
DRUG: Cisplatin
DRUG: Gemcitabine
DRUG: Paricalcitol

Sponsor

Barts & The London NHS Trust